Patrick Gallagher

Chair, Pharmaceuticals and Biopharmaceuticals Litigation and Regulatory group at Duane Morris LLP
On the record
Represented by:
Recent Quotes
Sign up to view all
  • When they made it an option not to submit it to FDA, that’s an option nearly everyone took. That’s the cautionary tale for the therapeutics and the vaccine for FDA and regulators around the world to make sure they’re making the process as efficient as possible but still making sure they’re getting enough data to be sure they’re comfortable and confident.

    28 November 2020
Employment
Sign up to view all
  • Duane Morris LLP
    Chair, Pharmaceuticals and Biopharmaceuticals Litigation and Regulatory group